Denali Therapeutics Inc. Common Stock

DNLINASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
19.52 USD
↘ 0.62 (3.08%)AT CLOSE (11:59 AM EDT)
19.50
↘ 0.02 (0.10%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
19.50
↘ 0.02 (0.10%)
🔴Market: CLOSED
Open?$19.94
High?$19.94
Low?$19.24
Prev. Close?$20.14
Volume?2.2M
Avg. Volume?1.9M
VWAP?$19.55
Rel. Volume?1.18x
Bid / Ask
Bid?$18.90 × 100
Ask?$21.00 × 100
Spread?$2.10
Midpoint?$19.95
Valuation & Ratios
Market Cap?3.1B
Shares Out?158.7M
Float?128.2M
Float %?87.4%
P/E Ratio?N/A
P/B Ratio?3.35
EPS?-$3.21
Dividend?0.00%
Ex-Dividend?N/A

DNLI is currently priced at $19.52. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. DNLI is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

RelatedBEAM
News
Profile
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
507
Market Cap
3.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.denalitherapeutics.com
Listed
2017-12-08
Address
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 866-8547
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
54
Momentum?
65
Short Sent.?
39
Piotroski F-Score?0/9Weak
Altman Z-Score?2.50Grey
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.94%High
Short Interest?14.0M
Days to Cover?7.5
Free Float128.2M
Avg Daily Volume1.9M
Settlement Date2026-05-15
Financial Health
Current Ratio?9.28Strong
Quick Ratio?9.28Strong
Cash Ratio?3.52Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
50
S&P
50
3.35FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-55.0%WEAK▾
ROA?
S&P
3
-40.2%WEAK▾
Cash Flow & Enterprise
FCF?$-419226000
Enterprise Value?$2.7B
Fundamentals ratios updated end of day
MarketsMoversWatchlist